-+ 0.00%
-+ 0.00%
-+ 0.00%

Barinthus Biotherapeutics Q1 EPS $(0.49) Misses $(0.36) Estimate

Benzinga·05/07/2025 13:20:19
Listen to the news
Barinthus Biotherapeutics (NASDAQ:BRNS) reported quarterly losses of $(0.49) per share which missed the analyst consensus estimate of $(0.36) by 36.11 percent. This is a 22.5 percent decrease over losses of $(0.40) per share from the same period last year.